Skip to Content

DROXIA 6335 DROXIA 6335 (Droxia 200 mg)

Generic Name: hydroxyurea

Pill with imprint DROXIA 6335 DROXIA 6335 is Green, Capsule-shape and has been identified as Droxia 200 mg. It is supplied by Bristol-Myers Squibb.

Droxia is used in the treatment of anemia, sickle cell; solid tumors and belongs to the drug class antimetabolites. There is positive evidence of human fetal risk during pregnancy. Droxia 200 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for DROXIA 6335 DROXIA 6335

Droxia 200 mg DROXIA 6335 DROXIA 6335
Droxia 200 mg DROXIA 6335 DROXIA 6335
Droxia 200 mg DROXIA 6335 DROXIA 6335

Droxia

Generic Name:
hydroxyurea
Imprint:
DROXIA 6335 DROXIA 6335
Strength:
200 mg
Color:
Green
Size:
16.00 mm
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Antimetabolites
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Bristol-Myers Squibb
Inactive Ingredients:
citric acid monohydrate
gelatin
lactose
magnesium stearate
sodium phosphate
titanium dioxide
FD&C Blue No. 1
FD&C Green No. 3
Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide